SC
WVE icon

SummitTX Capital’s Wave Life Sciences WVE Stock Holding History

SummitTX Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-53,611
Closed -$392K – 995
2025
Q3 		$392K Buy
+53,611
New +$434K 0.02% 575
2025
Q2 		– Sell
-25,249
Closed -$204K – 1041
2025
Q1 		$204K Buy
+25,249
New +$276K 0.01% 732

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

SummitTX Capital's WVE Position: Q4 2025 in Review

SummitTX Capital sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 53,611 shares — an estimated $392K sold.

SummitTX Capital first reported a position in WVE in Q1 2025 and held it in 2 quarters. The position peaked at $392K in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • SummitTX Capital reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • SummitTX Capital sold 53,611 Wave Life Sciences shares in Q4 2025, an estimated $392K.
  • SummitTX Capital first reported a position in Wave Life Sciences in Q1 2025 and held it in 2 quarters.
  • SummitTX Capital's Wave Life Sciences position peaked at $392K in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.